The immunological bases of alemtuzumab as induction-therapy in pediatric-onset multiple sclerosis by Marco Puthenparampil, Marco Puthenparampil, Marco Puthenparampil, Marta Gaggiola, Marta Gaggiola, Francesca Rinaldi, M. Nosadini, M. Nosadini, S. Sartori, S. Sartori, Paola Perini, Paolo Gallo, Paolo Gallo

Subjects: Get full text

The efficacy and safety of induction chemotherapy combined with sintilimab followed by concurrent chemoradiotherapy plus sintilimab sequencing maintaining with sintilimab for patie... by Ruifeng Wang, Tianhui Guo, Qi Wang, Wen Gao, Yimiao Yu, Jun Zhang, Wenqian Fu, Haiji Wang, Biyuan Zhang

Subjects: Get full text

Incidence, Risk Factors, and Treatment Outcome of Acute Renal Allograft Rejection by Remyasri Akhil, Eby Mathew, Bipi Prasannan, Vishnu Dev Urs, V. Narayanan Unni

Subjects: Get full text

Comparison of BCG Tokyo172 Strain Induction Therapy Between Low Dose and Standard Dose for Non-Muscle Invasive Bladder Cancer: Intravesical Instillation of BCG Tokyo172 Strain by Hideyuki Isobe, Fumitaka Shimizu, Takeshi Ieda, So Nakamura, Naoko Takazawa, Hanna Suetsugu, Kazunori Kajino, Shu Hirai, Hisashi Hirano, Katsuhito Yuzawa, Shigeo Horie

Subjects: Get full text